Short-term and long-term evolution of deep vein thrombosis treated by a health care unit;Evolución a corto y largo plazo de la trombosis venosa profunda, tratada por una unidad de hospitalización a Domicilio

Revista Clinica Espanola

Volumn 202, Issue 8, 2002, Pages 430-434

  Martin Carbonero L ^a   Salgado, X ^a   Pedrajas, J M ^a   Armengol, J G ^a   Jimenez Rodriguez Madridejos R ^a   Fernandez Cruz A ^a  

^a Departamento de Medicina Interna   (Spain)

Author keywords

Ambulatory treatment; Deep vein thrombosis; Low molecular weight heparin

Indexed keywords

ACENOCOUMAROL; AMINOTRANSFERASE; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; ARTICLE; BLEEDING; CAUSE OF DEATH; CLINICAL OBSERVATION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; HEALTH CARE; HEALTH SURVEY; HIGH RISK POPULATION; HOME CARE; HUMAN; INTERNAL MEDICINE; LIVER TOXICITY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; PHLEBITIS; RELAPSE; RISK FACTOR; SAFETY; THROMBOEMBOLISM;

AGED; AMBULATORY CARE; ANTICOAGULANTS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; NADROPARIN; SURVIVAL ANALYSIS; VENOUS THROMBOSIS;

EID: 0036697093     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155-60.
2. Lensin AW, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous thrombosis with low-molecular-weigth-heparins. Arch Intern Med 1995;155:601-7.
3. Leizorovics A. Comparison of the efficacy and safety of low molecular weight heparins and unfractionated heparin in the initial treatment of deep vein thrombosis. Drugs 1996;52 Suppl 7:30-7.
4. Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-Molecular-Weigth-Heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 1999;130:800-9.
5. Hirsh J, Levine MN. Low molecular weight heparine. Blood 1992;79:1-17.
6. Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-molecular-weigth-heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med 1999;130:789-99.
7. Boccalon H, Elias A, Chalé JJ, Cadéne A, Gabriel S. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with low-molecular-weight-heparin. Arch Intern Med 2000;160:1769-73.
8. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, et al. A comparison of low-molecular-weigth-heparins administered primarily at home with unfractionated heparin administered in the hospital for deep vein thrombosis. N Engl J Med 1996;334(11):677-81.
9. Koopman M, Prandoni P, Piovella F, Ockelford P, Brandjes D, Van der Meer J. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight-heparins administered at home. N Engl J Med 1996;334(11):682-7.
10. Villalta S, Bagatella P, Piccioli A, Lensing AWA, Prins MH, Prandoni P. Assessment of validity and reproducibility of a clinical scale for the postthrombotic syndrome [abstract]. Haemostasis 1994;24 Suppl 1: 158.
11. Spiro TE, Johnson GJ, Christie MJ, Lyons RM, MacFarlane DE, Blasier RB, et al. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement sugery. Ann Intern Med 1994;121:81-9.
12. Prandoni P, Lensing A, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7.
13. Schulman S, Rhedin AS, Lindmarder P, Carlsson A, Larfars G, Nicol P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995;332:1661-5.
14. Brandjes DPM, Büller HR, Heijboer H, Huisman MV, Rijk M, Jagt H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997;349:759-62.
15. Biguzzi E, Mozzi E, Alatri A, Taioli E, Moia M, Mannucci PM. The post-thrombotic syndrome in young women: retrospective evaluation of prognostic factors. Thromb Haemost 1998;80:575-7.
16. Holmström M, Aberg W, Lockner D, Paul C. Long-term clinical follow-up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin: a retrospective analysis. Thromb Haemost 1999;82:1222-6.
17. Wells P, Dovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, et al. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with Low Molecular Weigth Heparin. Arch Intern Med 1998;158:1089-812.
18. Dunn AS, Coller B. Outpatients treatment of deep vein thrombosis: translating clinical trials into practice. Am J Med 1999;106:660-9